Onward Medical N.V. (EBR:ONWD)

Onward Medical Statistics

Total Valuation

Onward Medical has a market cap or net worth of EUR 242.87 million. The enterprise value is 217.00 million.

Market Cap	242.87M
Enterprise Value	217.00M

Important Dates

The last earnings date was Thursday, September 4, 2025.

Earnings Date	Sep 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Onward Medical has 44.65 million shares outstanding. The number of shares has increased by 53.03% in one year.

Current Share Class	44.65M
Shares Outstanding	44.65M
Shares Change (YoY)	+53.03%
Shares Change (QoQ)	-18.29%
Owned by Insiders (%)	6.45%
Owned by Institutions (%)	18.16%
Float	26.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	89.42
PB Ratio	8.76
P/TBV Ratio	13.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.61
EV / Sales	79.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.01

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.54.

Current Ratio	4.34
Quick Ratio	3.92
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-0.42
Interest Coverage	-12.01

Financial Efficiency

Return on equity (ROE) is -167.80% and return on invested capital (ROIC) is -57.47%.

Return on Equity (ROE)	-167.80%
Return on Assets (ROA)	-43.66%
Return on Invested Capital (ROIC)	-57.47%
Return on Capital Employed (ROCE)	-78.49%
Revenue Per Employee	26,369
Profits Per Employee	-375,252
Employee Count	103
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, Onward Medical has paid 458,000 in taxes.

Income Tax	458,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.75% in the last 52 weeks. The beta is 0.95, so Onward Medical's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+15.75%
50-Day Moving Average	4.56
200-Day Moving Average	4.82
Relative Strength Index (RSI)	66.68
Average Volume (20 Days)	154,016

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onward Medical had revenue of EUR 2.72 million and -38.65 million in losses. Loss per share was -0.78.

Revenue	2.72M
Gross Profit	-10.54M
Operating Income	-36.07M
Pretax Income	-38.19M
Net Income	-38.65M
EBITDA	-35.70M
EBIT	-36.07M
Loss Per Share	-0.78

Balance Sheet

The company has 40.93 million in cash and 15.06 million in debt, giving a net cash position of 25.87 million or 0.58 per share.

Cash & Cash Equivalents	40.93M
Total Debt	15.06M
Net Cash	25.87M
Net Cash Per Share	0.58
Equity (Book Value)	27.72M
Book Value Per Share	0.62
Working Capital	34.93M

Cash Flow

In the last 12 months, operating cash flow was -35.77 million and capital expenditures -348,000, giving a free cash flow of -36.12 million.

Operating Cash Flow	-35.77M
Capital Expenditures	-348,000
Free Cash Flow	-36.12M
FCF Per Share	-0.81

Margins

Gross Margin	n/a
Operating Margin	-1,327.98%
Pretax Margin	-1,406.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onward Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.03%
Shareholder Yield	n/a
Earnings Yield	-15.91%
FCF Yield	-14.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Onward Medical has an Altman Z-Score of -2.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.06
Piotroski F-Score	3